Zhejiang medical supplies with volume procurement program out of the price reduction came

Pharmaceutical Network May 27 - May 25, Zhejiang Province Pharmaceutical Procurement Center in accordance with the Zhejiang Provincial Medical Security Bureau, "Zhejiang Province Public Medical Institutions part of the medical supplies band procurement work program (draft for comments)", the preparation of "Zhejiang Province public medical institutions part of the medical supplies band purchase document (draft for comments)."announced the procurement plan for coronary intervention drug stents, coronary intervention sacs, orthopaedic hip medical supplies, this procurement cycle is 2 yearsthe annual purchase volume of the public medical institutions in Zhejiang Province in 2019 80% of the transaction volumeThe document points out that in the remaining amount, agreed to purchase the remaining amount of the amount, medical institutions can still purchase the provincial pharmaceutical procurement platform in this centralized band procurement of unmarked products (whether or not participate in this centralized band procurement)but the transaction amount of similar products shall not exceed 20% of the annual transaction amount of the medical institution, and the transaction price shall not be higher than 150% of the maximum price of the winning productIt is worth noting that this centralized band procurement review is divided into expert review and business standard review, very point of viewat the expert review stageBid products are evaluated by experts in groups of secondary catalogues, and each group of tender edgy products is ranked from highest to lowestthe number of bidding products in the secondary catalogue group does not exceed 4, all products shall enter the commercial bid review;in the business standard review phaseEnter the commercial bid review of the product for quotation, the quotation is higher than the secondary catalog reference price of the product phase-out, the lowest price of the remaining products identified as the preferred product, other products according to the number of winning places in order to determine the price from low to high to determine the selected product50% of the annual purchase volume is allocated to the preferred product according to the principle of price linkage, and 50% of the remaining annual purchase volume is distributed according to the lowest to the high price of the winning productsuch as the winning price of selected products from low to high are: A1 productb1 yuan, A2 product B2 yuan ..An product Bn yuan, then the annual purchase volume allocation ratio is calculated as follows:A1 product annual procurement volume allocation ratio of 50% - Bn/B1/ (Bn/B1 plus Bn/Bn/Bn2 plus.?An product annual purchase allocation ratio : 50% of the amount of Bn / Bn / Bn / B2 plus only one , 70% of the annual purchase is allocated to the preferred product and 30% to the selected product you can see that the quoted product is likely to be the preferred product 　　Recently, according to the National Health Insurance Administration news: will soon launch the second batch of collection, while the pilot provinces of comprehensive medical reform to take the lead in exploring the and high-value medical supplies not included in the centralized procurement of national organizations to carry out volume procurement, other provinces should also actively follow up the future procurement of high-value consumables will be based on medical insurance payment, the establishment of , , transactions, settlement, supervision and integration of provincial tender procurement platform, promote the construction of regional, national alliance procurement mechanism, the formation of full competition, reasonable prices, standardized and orderly supply security system the National Health Insurance Administration said that the next step, the National Health Insurance Administration will choose key varieties to implement the "band procurement" pilot work, reduce the price of high-value medical supplies, benefit the people for the varieties of negotiations, the National Health Insurance Administration said in its reply, to consider a variety of factors, to explore in line with the characteristics of medical supplies tender to establish a negotiation mechanism for exclusive products or patent-period products with high clinical value and high market price, and to use medical insurance reimbursement as leverage to promote its reasonable formation of prices.